SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Clark Gregory S. (Last) (First) (Middle) 350 ELLIS STREET (Street) MOUNTAIN VIEW CA 94043 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol SYMANTEC CORP [ SYMC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) CEO
	3. Date of Earliest Transaction (Month/Day/Year) 08/01/2016
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/01/2016		A		207,907(1)	A	(1)	207,907	I	Gregory S Clark TR UA 01/29/2016 Gregory S Clark Living Trust
Common Stock	08/01/2016		A		2,121,613(2)	A	(2)	2,329,520	I	GSC-OZ Investment LLC
Common Stock	08/01/2016		A		433,526(3)	A	$0.00	2,763,046	D
Common Stock	08/01/2016		A		433,526(4)	A	$0.00	3,196,572	D
Common Stock	08/01/2016		A		260,115(5)	A	$0.00	3,456,687	D
Common Stock	08/01/2016		A		152,028(6)	A	$0.00	3,608,715	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$6.73	08/01/2016		A		3,865,271		(7)	09/09/2025	Common Stock	3,865,271	(8)	3,865,271	D

Explanation of Responses:

1. Shares acquired pursuant to the Restricted Stock Reinvestment Agreement, dated as of June 12, 2016 with Symantec Corporation ("Symantec"). Shares will vest in equal monthly installments beginning August 30, 2016 and ending on October 30, 2019.

2. Shares acquired pursuant to the LLC Reinvestment Agreement, dated as of June 12, 2016 with Symantec.

3. Shares acquired pursuant to the merger (the "Merger") in which a wholly owned subsidiary of Symantec was merged with and into Blue Coat, Inc. ("Blue Coat"). The Reporting Person held 246,749.05 restricted stock units to acquire Blue Coat common stock that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest fully in one installment on November 12, 2016.

4. Shares acquired pursuant to the Merger. The Reporting Person held 246,749.05 restricted stock units to acquire Blue Coat common stock that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest fully in one installment on November 12, 2017.

5. Shares acquired pursuant to the Merger. The Reporting Person held restricted stock units to acquire 148,049.43 shares of common stock of Blue Coat that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest 30% on August 1, 2017, 30% on August 1, 2018, and 40% on August 1, 2019.

6. Shares acquired pursuant to the Merger. The Reporting Person held restricted stock units to acquire 86,529.96 shares of common stock of Blue Coat that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest 30% on August 1, 2017, 30% on August 1, 2018, and 40% on August 1, 2019.

7. The option vests and becomes exercisable in equal monthly installments over a period of two years, beginning August 1, 2016.

8. Acquired pursuant to the Merger. The Reporting Person held an employee stock option to acquire 2,600,000 shares of Blue Coat common stock for $10.00 per share that was exchanged for this option to purchase shares of common stock of Symantec in the Merger.

Remarks:

	/s/ Philip Reuther, as attorney-in-fact for Gregory S. Clark	08/03/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.